Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
2.
J Exp Clin Cancer Res ; 20(1): 51-6, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11370830

RESUMO

The number of colorectal tumors per mouse induced by 1,2-dimethylhydrazine in transgenic (Tg) mice carrying human c-Ha-ras genes was significantly reduced by ingestion of apple pectin (AP) or a culture condensate of Bifidobacterium longum(MB) compared with a control diet and non-Tg mice. However, there were no differences in the composition of fecal flora, water content, beta-glucuronidase and beta-glucosidase activities, and concentrations of organic acids and putrefactive products in the feces between the AP or MB diet and the control diet, or between the Tg mice and non-Tg mice. The concentration of secondary bile acids in the MB diet group was higher than that in the control group. These results suggested that there was no relationship between prevention of colorectal tumors in Tg mice and the AP or MB diet, or improvement of the intestinal environment due to these functional foods.


Assuntos
Bifidobacterium , Neoplasias Colorretais/genética , Neoplasias Colorretais/prevenção & controle , Genes ras , Pectinas/uso terapêutico , 9,10-Dimetil-1,2-benzantraceno , Animais , Neoplasias do Colo/genética , Neoplasias do Colo/patologia , Neoplasias do Colo/prevenção & controle , Neoplasias Colorretais/patologia , Fezes/química , Fezes/microbiologia , Feminino , Frutas , Glucuronidase/metabolismo , Humanos , Masculino , Camundongos , Camundongos Endogâmicos , Camundongos Transgênicos , Neoplasias Retais/genética , Neoplasias Retais/patologia , Neoplasias Retais/prevenção & controle , beta-Glucosidase/metabolismo
3.
Exp Anim ; 49(4): 305-7, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11109558

RESUMO

The number and tumor score of colorectal tumors induced by 1,2-dymethylhydrazine in transgenic (Tg) mice carrying human c-Ha-ras genes were significantly reduced by ingestion of apple pectin (AP) or a culture condensate of Bifidobacterium longum (MB) when compared with a control diet. There was no statistical difference in the incidence of colorectal tumors in Tg mice between the AP or MB diet and the control diet. This study demonstrated that Tg mice are a useful tool for screening inhibition of colorectal tumors by functional foods.


Assuntos
Bifidobacterium , Neoplasias Colorretais/tratamento farmacológico , Meios de Cultura , Genes ras , Pectinas/uso terapêutico , 1,2-Dimetilidrazina , Administração Oral , Animais , Neoplasias Colorretais/induzido quimicamente , Neoplasias Colorretais/epidemiologia , Neoplasias Colorretais/genética , Feminino , Frutas , Humanos , Masculino , Camundongos , Camundongos Transgênicos , Pectinas/administração & dosagem
4.
Anticancer Res ; 19(5B): 4139-43, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10628365

RESUMO

The inhibitory effect of a synthetic retinoid, ethyl alltrans-9-(4-methoxy-2, 3, 6-trimethyl-phenyl)-3, 7-dimethyl-2, 4, 6, 8-nonatetraenoate (Tigason), on esophageal carcinogenesis in F344 rats induced by N-nitroso-N-methylbutylamine (NMBA) was evaluated. The animals were given NMBA daily in their drinking water for 21 weeks at a concentration of 15 mg per liter ad libitum starting at 8 weeks of age. One week before the beginning of NMBA treatment, the rats were divided randomly into Tigason-fed and -unfed groups. Thirty-five rats were fed a diet supplemented with Tigason at a concentration of 30 mg per kg of diet, and 80 rats were given a basal diet alone. In NMBA-treated rats, multiple papillomas were seen 11 weeks after NMBA treatment and squamous cell carcinoma developed 12 weeks after NMBA; the tumors increased in number thereafter, and the numbers of papillomas and carcinomas were the same at 17 and 21 weeks after NMBA. At 21 weeks after NMBA treatment, the number of papillomas was similar, regardless of the dietary Tigason supplement, however, the number of esophageal squamous cell carcinomas was significantly lower in the Tigason-fed rats than in -unfed animals (p < 0.025). In normal esophageal tissues, a small amount of cellular retinoic acid-binding protein (cRABP) was detected throughout the experimental period, while during carcinogenesis, the levels of cRABP increased continuously until 16 weeks after NMBA; the cRABP level was higher in papillomas than in squamous cell carcinomas. As Tigason specificially blocked the progression of papillomas to carcinomas, it may be a promising candidate chemopreventive agent in esophageal carcinogenesis.


Assuntos
Carcinógenos , Neoplasias Esofágicas/induzido quimicamente , Neoplasias Esofágicas/tratamento farmacológico , Etretinato/farmacologia , Ceratolíticos/farmacologia , Nitrosaminas/farmacologia , Receptores do Ácido Retinoico/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/patologia , Neoplasias Esofágicas/patologia , Esôfago/efeitos dos fármacos , Esôfago/patologia , Masculino , Mucosa/efeitos dos fármacos , Mucosa/patologia , Papiloma/induzido quimicamente , Papiloma/tratamento farmacológico , Papiloma/patologia , Ratos , Ratos Endogâmicos F344 , Fatores de Tempo
5.
Anticancer Res ; 18(3A): 1621-7, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9673380

RESUMO

To evaluate the effects of dietary fats on breast cancer growth and metastasis, KPL-1 human breast carcinoma cells which have a propensity for axillary lymph node metastasis when inoculated into the thoracic mammary fat pad of female nude mice were examined. The mice were fed one of three semipurified diets containing 9.5% eicosapentaenoic acid plus 0.5% linoleic acid (EPA diet), 10% linoleic acid (LA diet), or 9.5% palmitic acid plus 0.5% linoleic acid (PA diet), or commercial laboratory chow containing 8.5% fat of which 4.1% was LA, 1.1% was PA, 0.06% was EPA, and 3.24% was other (Standard diet) starting 19 days before tumor cell inoculation and continuing until the end of the experiment (43 days after tumor cell inoculation). The tumor growth was faster and at a higher incidence in the mice fed the LA diet, and much slower and at a lower incidence in the EPA diet group compared with the mice fed the PA or Standard diet; the two separate experiment demonstrated identical results. The differences in tumor weight between the LA and PA groups and between the PA and EPA groups were significant (P < 0.05, respectively) at the termination of the experiment; the differences were due to different tumor cell proliferation rates. In an in vitro MTT assay, fatty acids showed direct stimulatory or inhibitory effects on the KPL-1 cells. Lymph node metastasis was seen in the LA and Standard diet groups, whereas it was not seen in the PA or EPA groups. The body weights were significantly lighter in the LA and EPA groups compared with the PA and Standard diet groups (P < 0.05, respectively). The results indicate that the EPA diet produced a reduction in tumor cell growth and metastasis whereas the LA diet had an enhancing effect on these parameters; dietary fatty acids may thus have a direct role in the growth and metastasis of human breast carcinoma independent of their systemic effects.


Assuntos
Neoplasias da Mama/patologia , Gorduras Insaturadas na Dieta/farmacologia , Gorduras na Dieta/farmacologia , Ácidos Graxos não Esterificados/farmacologia , Metástase Linfática , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Ácido Eicosapentaenoico/farmacologia , Feminino , Humanos , Cinética , Ácido Linoleico/farmacologia , Camundongos , Camundongos Nus , Metástase Neoplásica , Ácido Palmítico/farmacologia , Fatores de Tempo , Transplante Heterólogo , Células Tumorais Cultivadas
6.
Breast Cancer Res Treat ; 45(1): 15-27, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9285113

RESUMO

Antitumor and antimetastatic activity of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470), a semisynthetic analogue of fumagillin, was evaluated in breast cancer cell lines. In an in vitro MTT assay, after 72 hrs continuous exposure to TNP-470, growth inhibition was observed in all seven cell lines of murine (JYG-A, JYG-B, DD-762, and BALB/c-MC) or human (KPL-1, MDA-MB-231, and MKL-F) origin, in which the 50% inhibitory concentrations (IC50) at 72 hrs treatment were 4.6, 4.4, 4.6, 10.1, 35.0, 25.3, and 33.4 micrograms/ml, respectively. In an in vivo assay using JYG-A, JYG-B, KPL-1, and MDA-MB-231 cells by orthotopic (right thoracic mammary fat pad) transplantation in female nude mice, TNP-470 at 30 or 50 mg/kg body weight was injected s.c. every other day from the day of tumor cell inoculation until the end of the experiment. The inhibitory effect on primary tumor growth was obtained in all four cell lines in a dose-dependent manner. In the 50 mg/kg TNP-470-treated group, the reductions in tumor weight of the JYG-A, JYG-B, KPL-1, and MDA-MB-231 cells with respect to the controls were 50%, 30%, 4%, and 49%, respectively. Metastasis was seen in the JYG-A, JYG-B, and KPL-1 cells. The numbers of mice bearing pulmonary metastases of JYG-A and JYG-B cells and regional axillary lymph node metastases of KPL-1 cells were reduced, and TNP-470 at the 50 mg/kg dose to KPL-1 cells significantly reduced lymph node metastases compared with the control. Although the weight gain was retarded in the TNP-470-treated mice, weight loss was not seen. TNP-470 was highly effective in the treatment of breast cancer cells. These results suggest that the clinical use of TNP-470 may be a promising treatment for breast cancer patients.


Assuntos
Antibióticos Antineoplásicos/uso terapêutico , Neoplasias Mamárias Experimentais/tratamento farmacológico , Sesquiterpenos/uso terapêutico , Animais , Neoplasias da Mama/tratamento farmacológico , Divisão Celular/efeitos dos fármacos , Cicloexanos , Feminino , Humanos , Neoplasias Pulmonares/secundário , Metástase Linfática , Neoplasias Mamárias Animais/tratamento farmacológico , Neoplasias Mamárias Experimentais/patologia , Camundongos , Camundongos Nus , Metástase Neoplásica/prevenção & controle , Transplante de Neoplasias , O-(Cloroacetilcarbamoil)fumagilol , Células Tumorais Cultivadas/efeitos dos fármacos
7.
Nutr Cancer ; 16(2): 153-64, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1665559

RESUMO

The effects of selenium supplementation on induction of cholangiocarcinomas and related precancerous lesions in female Syrian Golden hamsters by N'-nitrosobis(2-oxopropyl)amine (BOP) were investigated. Four-week-old animals were divided into two groups according to the selenium level contained in the drinking water (0.1 ppm or 4.0 ppm) and fed a purified diet containing less than 0.05 ppm of the trace element. Starting at Week 4 of the experiment, hamsters were administered 10 weekly injections of BOP (10 mg/kg body wt) and then killed 18 weeks after the last carcinogen administration. Animals receiving physiological saline alone served as controls. Cholangiocellular carcinomas tended to be reduced, and putative preneoplastic lesions of cholangiofibrosis were significantly decreased in the high-as opposed to the low-selenium groups in terms of both incidence rate and number per effective animal. The respective high and low selenium values for incidence and number were 24/38% and 0.34/0.66, respectively, for cholangiocarcinomas and 50/89% and 1.21/8.44, respectively, for cholangiofibroses. Proliferation of intrahepatic bile ducts was also significantly inhibited in the high-selenium group along with cyst formation. Biochemical investigation revealed both selenium level and glutathione peroxidase activity to be significantly greater in the high-than in the low-selenium group livers. The results thus suggest that selenium may inhibit BOP-induction of bile duct lesions, possibly via glutathione peroxidase-mediated alteration of carcinogenesis.


Assuntos
Adenoma de Ducto Biliar/prevenção & controle , Anticarcinógenos/uso terapêutico , Neoplasias Hepáticas/prevenção & controle , Nitrosaminas/antagonistas & inibidores , Selênio/uso terapêutico , Adenoma de Ducto Biliar/induzido quimicamente , Adenoma de Ducto Biliar/patologia , Animais , Anticarcinógenos/farmacologia , Peso Corporal/efeitos dos fármacos , Cricetinae , Feminino , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/patologia , Mesocricetus , Selênio/farmacologia
8.
Carcinogenesis ; 11(11): 2015-9, 1990 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2225334

RESUMO

We have investigated the effects of two qualitatively different types of unsaturated fatty acids on N-nitroso-N-methylurea (NMU)-induced mammary carcinogenesis in female Sprague-Dawley rats. Semipurified diets containing 4.7% eicosapentaenoic acid (EPA) plus 0.3% linoleic acid or 5% linoleic acid were prepared. Animals maintained on these diets were given an i.v. injection of NMU (50 mg/kg body wt) at 50 days of age and killed 20 weeks later. Both tumor incidence and tumor number per rat were significantly lower in the EPA diet group (60.0% and 2.3 +/- 2.5 versus 93.3% and 5.1 +/- 4.5 respectively) for the 5% linoleic acid diet. Furthermore, the average weight of tumor material (total) per rat was significantly lower in the EPA as compared to linoleic acid diet group (2.9 +/- 4.2 g and 11.4 +/- 12.2 g respectively). Analysis of phospholipid fatty acids in the mammary tumors in the EPA diet group showed a higher proportion of C16:0, C18:2, omega-3 fatty acids C20:5 and C22:6 and a lower proportion of C20:4. Furthermore, mammary tumors in rats fed the EPA diet demonstrated significant reduction in prostaglandins. The results thus suggest that inhibition by EPA of NMU-induced mammary carcinogenesis may be mediated via the modulation of lipid metabolism and associated reduction in prostaglandin synthesis.


Assuntos
Gorduras na Dieta/farmacologia , Ácido Eicosapentaenoico/farmacologia , Neoplasias Mamárias Experimentais/prevenção & controle , Animais , Ácidos Graxos/análise , Feminino , Neoplasias Mamárias Experimentais/induzido quimicamente , Metilnitrosoureia , Ratos , Ratos Endogâmicos
9.
Int J Cancer ; 46(1): 95-100, 1990 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-2365502

RESUMO

The effect of selenium intake on the development of pancreatic cancer was investigated in female Syrian golden hamsters. Four-week-old hamsters were divided into 2 groups according to the selenium level in their drinking water and were fed a purified diet containing less than 0.05 ppm selenium. Starting 4 weeks later, groups received 10 s.c. injections at weekly intervals of N'-nitrosobis(2-oxopropyl)amine (BOP) dissolved in saline, while controls received saline alone. When the animals were killed 18 weeks after the last injection, palpable tumors were less frequent in the high-selenium group than in animals receiving low-selenium supplement, the numbers of histologically diagnosed cancerous lesions also being significantly reduced by high selenium intake. The selenium level and glutathione peroxidase activity in serum and pancreas were significantly greater in the high-selenium group. Moreover, selenium levels and glutathione peroxidase activity were both significantly higher in tumor-bearing tissue. The results suggest that glutathione peroxidase is involved as an intermediate factor in prevention of carcinogenesis by selenium.


Assuntos
Carcinógenos/toxicidade , Nitrosaminas/toxicidade , Neoplasias Pancreáticas/induzido quimicamente , Selênio/farmacologia , Animais , Cricetinae , Depressão Química , Relação Dose-Resposta a Droga , Interações Medicamentosas , Feminino , Glutationa Peroxidase/metabolismo , Mesocricetus , Pâncreas/efeitos dos fármacos , Pâncreas/enzimologia , Neoplasias Pancreáticas/enzimologia , Selênio/administração & dosagem , Fatores de Tempo
10.
Nutrition ; 6(3): 241-5, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2136004

RESUMO

Preoperative plasma aminograms constructed for 63 patients expected to undergo gastrectomy for gastric cancer at different stages showed markedly lower concentrations of many plasma amino acids in the Stage IV and recurrent cases. The amino acid levels were inversely proportional to tumor size. On the other hand, preoperative arteriovenous differences in free amino acid levels were positive in Stage I cancer but negative in Stage IV cancer, indicating that intake of amino acids by the skeletal muscles exceeded the outflow in Stage I, whereas there was a net loss of amino acids from the skeletal muscles in advanced cancer. The amount of amino acids actually lost from the skeletal muscles after muscular loading in Stage I cancer also surpassed that in Stage IV cancer. Administration of TPN solution supplemented with 31% branched-chain amino acids (BCAA) might favorably influence muscle protein metabolism in gastric cancer patients by inhibiting protein degradation and promoting synthesis, as treatment was more effective than 21% BCAA-enriched TPN.


Assuntos
Aminoácidos de Cadeia Ramificada/administração & dosagem , Nutrição Parenteral Total/métodos , Neoplasias Gástricas/terapia , Aminoácidos/sangue , Aminoácidos de Cadeia Ramificada/sangue , Terapia Combinada , Feminino , Gastrectomia , Humanos , Masculino , Pessoa de Meia-Idade , Proteínas Musculares/metabolismo , Estadiamento de Neoplasias , Neoplasias Gástricas/sangue , Neoplasias Gástricas/cirurgia
11.
J Surg Res ; 47(2): 129-33, 1989 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2547111

RESUMO

Various regimens of total parenteral nutrition (TPN) and enteral feeding were compared to determine their effects on the structural and functional changes of rat small intestine. Male Wistar rats, allocated randomly into five groups on the basis of delivery route and composition of nutrients, were fed as follows: standard rat chow ad libitum (CE-2 group), low-residue diet (LRD group), LRD supplemented with 1% (w/v) fiber (LRD + fiber group), elemental diet (ED group), and TPN (TPN group). At 2 weeks of feeding, villi in the terminal ileum decreased in height in the following order: CE-2 group greater than LRD + fiber group greater than LRD group greater than ED group greater than TPN group. Mucosal diamine oxidase activity remained unchanged in the CE-2 group and LRD + fiber group throughout the experimental period. However, mucosal diamine oxidase values were significantly lower in the remaining three groups, similar to the structural changes, and those values in the ED group were significantly decreased at 2, 3, and 4 weeks. There was a positive correlation between plasma diamine oxidase level and mucosal diamine oxidase content, with a coefficient correlation of y = 0.20x + 0.03, r = 0.55 (P less than 0.01). These results could be interpreted to indicate that addition of dietary fiber to LRD has a favorable effect on the maintenance of intestinal architecture and function during enteral feeding, and plasma diamine oxidase activity can be used as an index of functional and/or structural changes occurring in the small intestine during enteral or parenteral feedings.


Assuntos
Fibras na Dieta/farmacologia , Nutrição Enteral , Intestino Delgado/anatomia & histologia , Nutrição Parenteral Total , Amina Oxidase (contendo Cobre)/sangue , Amina Oxidase (contendo Cobre)/metabolismo , Animais , Dieta , Fibras na Dieta/administração & dosagem , Ingestão de Energia , Alimentos Formulados , Mucosa Intestinal/anatomia & histologia , Mucosa Intestinal/enzimologia , Intestino Delgado/enzimologia , Intestino Delgado/fisiologia , Masculino , Ratos , Ratos Endogâmicos
12.
Cancer Res ; 48(17): 4790-4, 1988 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-2842039

RESUMO

The effects of eicosapentaenoic acid (EPA, n-3 polyunsaturated fatty acid) and linoleic acid (n-6 polyunsaturated fatty acid) on azoxymethane-induced colon carcinogenesis in rats were studied. Male Donryu rats were given two types of semipurified diet containing 4.7% EPA plus 0.3% linoleic acid and 5% linoleic acid. The rats were given s.c. injection of azoxymethane (7.4 mg/kg body weight once a week for 11 weeks) and sacrificed 15 weeks after the last injection of azoxymethane. The tumor incidence and tumor yields (tumors per rat) of the colon were significantly lower in rats on the EPA diet compared to those on the linoleic acid diet; i.e., 33%, 0.41 +/- 0.61 and 69%, 1.66 +/- 1.69, respectively. In the analysis of phospholipid fatty acid composition, the colon tumor showed higher levels of arachidonic acid and lower levels of linoleic acid than those in the normal colon mucosa in both diet groups. Despite the increase of arachidonic acid in colon tumor, the EPA diet suppressed the excessive production of prostaglandin E2, which may be accompanied with neoplastic formation, whereas linoleic acid diet caused a marked increase in the tumor content of prostaglandin E2 compared to normal colon mucosa. These results suggest that EPA exerts its inhibitory effect on colon carcinogenesis by modulating lipid metabolism and inhibiting prostaglandin E2 synthesis in tumor cells.


Assuntos
Neoplasias do Colo/prevenção & controle , Gorduras Insaturadas na Dieta/farmacologia , Ácido Eicosapentaenoico/farmacologia , Animais , Azoximetano , Ácidos e Sais Biliares/metabolismo , Colo/análise , Neoplasias do Colo/induzido quimicamente , Dinoprostona , Ácidos Graxos/análise , Masculino , Prostaglandinas E/análise , Ratos
13.
Cancer Res ; 46(5): 2266-70, 1986 May.
Artigo em Inglês | MEDLINE | ID: mdl-3697971

RESUMO

The influence of dietary selenium on the incidence of stomach carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine was studied in 108 rats that survived for over 10 wk. The incidence of glandular stomach cancer in the high-selenium (4.0 ppm) diet group (20 carcinomas in 54 rats) was lower than in the low-selenium (0.1 ppm) diet group (33 carcinomas in 54 rats). The selenium level and glutathione peroxidase activity in the blood, liver, and stomach mucosa were significantly higher in the high-selenium diet group than in the low-selenium diet group. Glutathione peroxidase activity as well as the concentration of selenium in the glandular stomach was increased significantly in the high-selenium diet group.


Assuntos
Metilnitronitrosoguanidina/antagonistas & inibidores , Selênio/farmacologia , Neoplasias Gástricas/diagnóstico , Adenocarcinoma/induzido quimicamente , Adenoma/induzido quimicamente , Animais , Peso Corporal/efeitos dos fármacos , Carcinoma/induzido quimicamente , Dieta , Mucosa Gástrica/metabolismo , Glutationa Peroxidase/metabolismo , Fígado/metabolismo , Ratos , Sarcoma Experimental/induzido quimicamente , Selênio/metabolismo
14.
Cancer Res ; 46(1): 61-5, 1986 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3940210

RESUMO

To determine whether the kind of dietary fat affects colon carcinogenesis, male Donryu rats were fed a 5% fat diet containing linoleate, an unsaturated fat, or stearate, a saturated fat, in semipurified fat-free chow. The rats were given azoxymethane (7.4 mg/kg body weight) s.c. once a week for 11 weeks and killed 15 weeks after the last injection of the carcinogen. The rats on the unsaturated fat diet had a significantly higher incidence of colon tumors. Fatty acid analysis of cholesterol esters in the liver and examination of the amount of fecal bile acids showed that the unsaturated fat diet increased the level of cholesterol linoleate and arachidonate in the liver and also increased the fecal excretion of bile acids, especially that of lithocholic acid. The colon tumors in rats on the unsaturated fat diet, compared with those in rats on the saturated fat diet, contained a higher level of lysophosphatidylcholine. These results suggest that increased fecal excretion of bile acids due to increased polyunsaturated cholesterol esters in the liver stimulates phospholipase A2 activity of colon initiated cells and enhances colon carcinogenesis in rats on the unsaturated fat diet.


Assuntos
Compostos Azo , Azoximetano , Ácidos e Sais Biliares/metabolismo , Neoplasias do Colo/etiologia , Gorduras na Dieta/metabolismo , Ácidos Graxos Insaturados/metabolismo , Ácidos Graxos/metabolismo , Animais , Colesterol/metabolismo , Ésteres do Colesterol/metabolismo , Fezes/metabolismo , Mucosa Intestinal/metabolismo , Fígado/metabolismo , Lisofosfatidilcolinas/metabolismo , Masculino , Fosfolipídeos/metabolismo , Ratos
15.
Dis Colon Rectum ; 28(5): 347-52, 1985 May.
Artigo em Inglês | MEDLINE | ID: mdl-3996152

RESUMO

A case of generalized peritonitis, secondary to a perforation of the rectosigmoid colon during barium-enema roentgenography, is presented. The patient required immediate surgical intervention with the prime importance of the treatment being removal of as much of the contaminating materials as possible. This was done successfully with irrigation and wiping, using urokinase solution. Peritoneal lavage with urokinase solution was also carried out in the early postoperative period. Fluid replacement with careful monitoring of fluid and electrolyte balance is essential before, during, and after the surgical procedure. Adequate antibiotic therapy and careful respiratory and nutritional support are also important.


Assuntos
Sulfato de Bário/efeitos adversos , Extravasamento de Materiais Terapêuticos e Diagnósticos/etiologia , Peritonite/induzido quimicamente , Idoso , Doenças do Colo/complicações , Enema , Humanos , Perfuração Intestinal/complicações , Masculino , Cavidade Peritoneal , Peritonite/patologia , Peritonite/cirurgia , Radiografia , Neoplasias Retroperitoneais/diagnóstico por imagem , Irrigação Terapêutica/métodos , Ativador de Plasminogênio Tipo Uroquinase/uso terapêutico
16.
Gan To Kagaku Ryoho ; 9(12): 2148-60, 1982 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-6820891

RESUMO

A randomized controlled study by envelope method was carried out with the purpose of evaluating effects and side effects of levamisole in patients with resectable stomach cancer. The patients were randomly allocated to the treatment either with control or levamisole according to the indication of the envelope opened at least 3 days prior to surgery. The control group was treated with Mitomycin C (day 0, 20 mg day 1, 10 mg, one shot i.v.) and 5-FU(150 mg/day, p.o.). The levamisole group was treated with Mitomycin C, 5-FU and levamisole. Levamisole was administered at a daily dose of 150 mg for 3 consecutive days before surgery, and the 3 consecutive days administration schedule was repeated every fortnight for one year after surgery. Four hundred and forty-six patients were entered in this trial. However, with the exclusion of 104 patients as exceptions and dropouts, the total eligible patients were 342, consisting of 167 in the control group and 175 in the levamisole group. The effects were evaluated by comparing the disease-free interval or the survival time of both groups. There was no significant difference in the disease-free interval and survival. In this study, we have not yet reached the conclusion that levamisole is effective in prolonging disease-free interval and survival time, because high survival rates are still maintained in both groups for 2 years after surgery. The final conclusion would be drawn with the follow-up results in the future.


Assuntos
Adjuvantes Imunológicos/administração & dosagem , Antibióticos Antineoplásicos/administração & dosagem , Fluoruracila/administração & dosagem , Levamisol/administração & dosagem , Mitomicinas/administração & dosagem , Neoplasias Gástricas/tratamento farmacológico , Adulto , Idoso , Ensaios Clínicos como Assunto , Esquema de Medicação , Quimioterapia Combinada , Feminino , Humanos , Levamisol/efeitos adversos , Masculino , Pessoa de Meia-Idade , Mitomicina , Distribuição Aleatória , Neoplasias Gástricas/mortalidade , Neoplasias Gástricas/cirurgia
17.
Exp Cell Biol ; 50(2): 115-9, 1982.
Artigo em Inglês | MEDLINE | ID: mdl-7075856

RESUMO

Human gastric carcinoma showed different growth in nude mice depending on their genetic backgrounds which included BALB/cA-nu (nude mice with a BALB/cA genetic background), CBA/N-nu, NFS/N-nu, NIH(s)-nu, C3H/HeN+-nu, C57BL/6N-nu and lasat mice (BALB/cA-nu, Dh). Rapid growth of human carcinoma was observed in CBA/N-nu, NFS/N-nu and NIH(s)-nu. The human carcinoma in NIH(s)-nu showed the widest deviation in tumor weight. These data suggest that NFS/N-nu and CBA/N-nu are strains which are more recommended for anticancer agent screening systems than BALB/cA-nu, NIH(s)-nu, C3H/HeN+-nu, C57BL/6N-nu and lasat mice, although many other factors including productivity of the mice, strain differences in drug metabolism and drug toxicity must be considered.


Assuntos
Antineoplásicos/farmacologia , Avaliação Pré-Clínica de Medicamentos/métodos , Camundongos Nus/genética , Neoplasias Experimentais/tratamento farmacológico , Animais , Divisão Celular , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos , Transplante de Neoplasias , Neoplasias Experimentais/patologia , Especificidade da Espécie , Neoplasias Gástricas/tratamento farmacológico , Transplante Heterólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA